Patient Education Liaison
Sarepta Therapeutics | |
United States, Georgia, Atlanta | |
Feb 06, 2026 | |
|
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We're looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients. What Sarepta Offers At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas:
For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us The Importance of the Role Reporting to the Executive Director, Patient Engagement Liaisons, the Patient Engagement Liaison (PEL) will serve as the primary point of contact for families during the treatment discovery phase for Elevidys, providing clear, compassionate education to support informed treatment discussions with their care team. As a PEL your role involves supporting patients and caregivers interested in learning about a treatment option for Duchenne Muscular Dystrophy (DMD). This field-based position provides educational assistance to patients and caregivers considering or undergoing therapy. Key responsibilities include supporting the Duchenne community at events, collaborating with patients, families, and serving as a trusted, educational resource for patients and caregivers during the treatment consideration phase. This role is dedicated to providing an educational forum for families to learn more about Elevidys, helping them understand the therapy, available educational resources, and the broader support ecosystem. The PEL acts as a bridge between the patient community and Sarepta, ensuring families receive accurate, compassionate, and timely information to support informed decision-making. As a PEL you will work with various internal teams to meet local territory needs.The Opportunity to Make a Difference
More about You
Preferred
What Now? We're always looking for solution-oriented, critical thinkers. So, if you're comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply. #LI-Hybrid #LI-CM1 This position is hybrid, you will be expected to work on site at one of Sarepta's facilities in the United States and/or attend Company-sponsored in-person events from time to time. The targeted salary range for this position is $160,800 - $201,000 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta's compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity. Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. | |
Feb 06, 2026